181 related articles for article (PubMed ID: 11739181)
1. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis.
Quinn ER; Chan CH; Hadlock KG; Foung SK; Flint M; Levy S
Blood; 2001 Dec; 98(13):3745-9. PubMed ID: 11739181
[TBL] [Abstract][Full Text] [Related]
2. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia.
De Re V; De Vita S; Marzotto A; Rupolo M; Gloghini A; Pivetta B; Gasparotto D; Carbone A; Boiocchi M
Blood; 2000 Nov; 96(10):3578-84. PubMed ID: 11071657
[TBL] [Abstract][Full Text] [Related]
3. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen.
Chan CH; Hadlock KG; Foung SK; Levy S
Blood; 2001 Feb; 97(4):1023-6. PubMed ID: 11159532
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein.
Machida K; Kondo Y; Huang JY; Chen YC; Cheng KT; Keck Z; Foung S; Dubuisson J; Sung VM; Lai MM
J Virol; 2008 Jul; 82(13):6711-20. PubMed ID: 18417597
[TBL] [Abstract][Full Text] [Related]
6. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
7. A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disorders.
Minafò YA; Del Padre M; Cristofoletti C; Caprini E; Perez M; Aranburu A; Colantuono S; Gragnani L; Zignego AL; Pulsoni A; Di Napoli A; Casato M; Fiorilli M; Visentini M
Genes Immun; 2020 Feb; 21(2):131-135. PubMed ID: 32066891
[TBL] [Abstract][Full Text] [Related]
8. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus, B-cell proliferation and lymphomas.
Gasparotto D; De Re V; Boiocchi M
Leuk Lymphoma; 2002 Apr; 43(4):747-51. PubMed ID: 12153160
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library.
Chan SW; Bye JM; Jackson P; Allain JP
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2531-9. PubMed ID: 8887487
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
Sarobe P; Huarte E; Lasarte JJ; López-Díaz de Cerio A; García N; Borrás-Cuesta F; Prieto J
J Hepatol; 2001 Feb; 34(2):321-9. PubMed ID: 11281563
[TBL] [Abstract][Full Text] [Related]
12. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.
Weiner AJ; Geysen HM; Christopherson C; Hall JE; Mason TJ; Saracco G; Bonino F; Crawford K; Marion CD; Crawford KA
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3468-72. PubMed ID: 1314389
[TBL] [Abstract][Full Text] [Related]
13. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
Shawky H; Maghraby AS; Solliman Mel-D; El-Mokadem MT; Sherif MM; Arafa A; Bahgat MM
Arch Virol; 2015 Apr; 160(4):945-58. PubMed ID: 25631616
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2.
Hu YW; Rocheleau L; Larke B; Chui L; Lee B; Ma M; Liu S; Omlin T; Pelchat M; Brown EG
Virology; 2005 Feb; 332(2):538-49. PubMed ID: 15680419
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81.
Allander T; Drakenberg K; Beyene A; Rosa D; Abrignani S; Houghton M; Widell A; Grillner L; Persson MAA
J Gen Virol; 2000 Oct; 81(Pt 10):2451-2459. PubMed ID: 10993933
[TBL] [Abstract][Full Text] [Related]
16. Novel E2 Glycoprotein Tetramer Detects Hepatitis C Virus-Specific Memory B Cells.
Boisvert M; Zhang W; Elrod EJ; Bernard NF; Villeneuve JP; Bruneau J; Marcotrigiano J; Shoukry NH; Grakoui A
J Immunol; 2016 Dec; 197(12):4848-4858. PubMed ID: 27849172
[TBL] [Abstract][Full Text] [Related]
17. B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins.
Ng PP; Kuo CC; Wang S; Einav S; Arcaini L; Paulli M; Portlock CS; Marcotrigiano J; Tarr A; Ball J; Levy R; Levy S
Blood; 2014 Mar; 123(10):1512-5. PubMed ID: 24449209
[TBL] [Abstract][Full Text] [Related]
18. Establishment of human clones producing neutralizing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus by EBV immortalization of immune CD22⁺ B cells.
Tabll A; El Abd Y; El Din NG; El Shenawy R; Abdelhafez TH; El Awady M; El-Mohamady H; Viazov S
Hum Antibodies; 2013; 22(3-4):55-65. PubMed ID: 24961863
[TBL] [Abstract][Full Text] [Related]
19. Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus.
Christie JM; Chapel H; Chapman RW; Rosenberg WM
Hepatology; 1999 Oct; 30(4):1037-44. PubMed ID: 10498657
[TBL] [Abstract][Full Text] [Related]
20. Screening HCV genotype-specific epitope peptides based on conserved sequence analysis and B cell epitope prediction in HCV E2 region.
Hua R; Jiang X; Qi L; Guan S; Kuai Z; Qiao Y; Xu Y; Gong X; Shi Y; Kong W; Niu J; Zhang H; Shan Y
Immunol Res; 2018 Feb; 66(1):67-73. PubMed ID: 29151181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
